首页> 外国专利> Method using desmoglein I protein in soluble form for screening anti-aging activator

Method using desmoglein I protein in soluble form for screening anti-aging activator

机译:使用可溶性形式的桥粒芯蛋白I蛋白筛选抗衰老活化剂的方法

摘要

Use of at least one (non)complexed soluble peptide form, derived at least partly from a polypeptide of amino acid sequence encoded by a nucleic acid sequence of SEQ ID NO: 1 (comprising a fully defined 4512 base pairs as given in the specification) or its analog as a screening tool of active ingredient for preventing and/or treating skin aging, is claimed. Independent claims are included for: (1) process for screening of anti-aging active ingredients comprising: (a1) contacting at least one cell type capable of releasing at least one soluble peptide form with at least one anti-aging active ingredient to be tested, under conditions favorable for releasing soluble peptide form; (b1) determining a content of the soluble peptide form; and (c1) comparing the content determined in step (b1) at a content of the soluble form determined in the absence of chemical or biological compound to be tested; (2) cosmetic process to characterize the effectiveness of a cosmetic or therapeutic treatment to prevent and/or treat the signs of skin aging linked to chronological aging in an individual, comprising at least qualitative and quantitative characterization of the soluble form; and (3) non-therapeutic process for characterizing the effectiveness of a treatment capable of preventing and/or treating the signs of skin aging in an individual, comprising: (i) placing at least a first sample of skin surface representative of the person; (ii) quantifying the level of the sample particularly using enzyme-linked-immunosorbent assay technique, at least as complex form; (iii) repeating the steps (i) and (ii) on a second sample of skin surface representative of the individual; and (iv) comparing the results obtained from steps (ii) and (iii), preferably to derive information related to at least one effect of the treatment, where the first and second samples of skin surface correspond to different treatment steps. ACTIVITY : Dermatological. MECHANISM OF ACTION : None given.
机译:至少一种(非)复合的可溶性肽形式的使用,其至少部分源自由SEQ ID NO:1的核酸序列编码的氨基酸序列的多肽(包含说明书中给出的完整定义的4512个碱基对)要求保护其或其类似物作为预防和/或治疗皮肤衰老的活性成分的筛选工具。包括以下独立权利要求:(1)筛选抗衰老活性成分的方法,包括:(a1)使至少一种能够释放至少一种可溶性肽形式的细胞类型与至少一种待测试的抗衰老活性成分接触在有利于释放可溶性肽形式的条件下; (b1)确定可溶性肽形式的含量; (c1)将步骤(b1)中确定的含量与在不存在要测试的化学或生物化合物的情况下确定的可溶形式的含量进行比较; (2)修饰过程,以表征预防和/或治疗与个体按时间顺序老化有关的皮肤衰老迹象的美容或治疗方法的有效性,至少包括定性和定量表征可溶性形式; (3)用于表征能够预防和/或治疗个体皮肤老化迹象的治疗的有效性的非治疗性方法,包括:(i)放置至少代表该人皮肤表面的第一样品; (ii)至少以复杂形式,尤其是使用酶联免疫吸附测定技术来定量样品的水平; (iii)在代表该个体的第二皮肤表面样品上重复步骤(i)和(ii); (iv)比较从步骤(ii)和(iii)获得的结果,优选地得出与至少一种治疗效果有关的信息,其中皮肤表面的第一和第二样品对应于不同的治疗步骤。活动:皮肤科。作用机理:未给出。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号